Mirna Therapeutics is now aiming to secure $44 million in an initial public offering, which is about $26 million less than it previously targeted. The Austin, Texas-based firm is focused on research for various types of cancer, including glioblastoma and ovarian cancer.
Semma Therapeutics has obtained $44 million in a Series A funding round that includes Medtronic as an investor. A cell therapy device is being developed by the Cambridge, Mass.-based startup as a treatment for type 1 diabetes.
Shaw Areva Mox Services has granted Alberici Constructors a $44 million subcontract for part of a planned facility in Aiken, S.C., that seeks to convert weapons-grade plutonium into nuclear fuel. Under the deal, Alberici will build the upper floors of the plant, where mixed oxide fuel would be produced.
Continental Airlines will take a $44 million charge in the second quarter to reflect the falling value of its 737 aircraft slated for retirement. Continental is retiring all of its 737-300 models and a "significant portion" of its 737-500s by January 2010.